Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. Commentary
- PMID: 20488329
- DOI: 10.1016/j.jvs.2010.02.019
Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. Commentary
Comment on
-
Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia.J Vasc Surg. 2010 Jun;51(6):1564-8. doi: 10.1016/j.jvs.2010.02.020. J Vasc Surg. 2010. PMID: 20488328 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
